Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation

Table 5 The use of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting post-transplant hepatocellular carcinoma recurrences

Ref.	Year	Follow-up (mo)	Recurrence		Disease-free survival	Risk of recurrence (95%CI)
			PET/CT (+)	PET/CT (-)
Yang et al[28]	2006	19	13/8	25/3	2-yr, 46.1% vs 85.1%	OR = 7.6 (1.9-28.9)
Kornberg et al[56]	2009	11.5	19/9	36/1	3-yr, 46.9% vs 93.3%	OR = 23.9 (2.1-268.5)
Lee et al[34]	2013	26.1	55/22	136/16	3-yr, 57.1% vs 86.8%	HR = 3.9 (1.1-13.0)
Hsu et al[37]	2016	25.8	30/9	117/9	5-yr, 68.3 vs 84.8%	HR = 13.5 (4.7-38.2)
Kornberg et al[57]	2017	74	41/24	75/5	5-yr, 38.1% vs 93.3%	HR = 22.8 (6.3-83.0)
Ye et al[63]	2017	25.7	78/46	25/7	5-yr, 21.9% vs 76%	HR = 3.6 (1.3-9.6)

PET/CT: Positron emission tomography/computed tomography.